Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity - Italy
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 440
- 试验地点
- 5
- 主要终点
- Validation of Patient reported outcome financial toxicity of cancer Italian(PROFTC-I) questionnaire
研究概览
简要总结
The aim of this study is to develop and validate a patient-reported-outcome instrument (PROFTC-I: Patient Reported Outcome Financial Toxicity in Cancer - Italy) able to describe and measure financial problems of Italian patients receiving cancer treatment.
详细描述
The project will be conducted according to the methodology delineated by the International Society for Pharmacoeconomics and Outcome Research (ISPOR) Patient Reported Outcomes Content Validity Good Research Practices Task Force in the following phases: concept elicitation and coding, item generation and analysis, instrument refinement and internal validation, and external validation.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients (>18 years)
- •Histologically or cytologically confirmed diagnosis of any type of solid cancer or haematological malignancy
- •Written Informed Consent provided
- •Medical treatment (chemotherapy, target agents, immunotherapy, hormonal treatment, radiotherapy or combinations of such therapies) ongoing or terminated within the previous 3 months.
- •Caregivers of patients who meet the above criteria
排除标准
- •Patients with major cognitive dysfunction or psychiatric disorders
- •Patients who have never received anticancer medical or radiation treatment
结局指标
主要结局
Validation of Patient reported outcome financial toxicity of cancer Italian(PROFTC-I) questionnaire
时间窗: 48 months
During the development of the questionnaire, individual items (questions), response options, and type of scoring will be determined according to Phases 1-3. Subsequently a principal components analysis (explorative factor analysis) will be done with eigen value set at 1; internal reliability will be assessed by inter-item correlations and Cronbach's alpha ( minimum acceptable 0.70); intraclass correlation coefficient (minimum acceptable 0.80). Correlation of final instrument with the EORTC quality of life questionnaire (criterion validity) will be assessed with using Pearson correlation coefficient.
次要结局
未报告次要终点